The Oncology Institute Inc TOI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.26
- Day Range
- $5.06–5.37
- 52-Week Range
- $2.32–6.67
- Bid/Ask
- $5.18 / $5.38
- Shares Outstanding
- 99.98M
- Market Cap
- $534.91M
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 641
Valuation
|
Metric
|
TOI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.97 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TOI
|
|---|---|
Quick Ratio | 1.13 |
Current Ratio | 1.47 |
Interest Coverage | −4.71 |
Quick Ratio
TOI
Profitability
|
Metric
|
TOI
|
|---|---|
Return on Assets (Normalized) | −19.77% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −26.44% |
Return on Assets
TOI
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| LOCK|@@h>g#Y | LOCK|!>ZN | $82B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|&bxc% | $27B | |||
| IHH Healthcare Bhd
IHHHF
| — | LOCK|J<F>P | $18B | |||
| Tenet Healthcare Corp
THC
| LOCK|Yp&TlP! | LOCK|St&d! | $17B | |||
| DaVita Inc
DVA
| LOCK|!nlD>T | LOCK|sY?q | $15B | |||
| Fresenius Medical Care AG
FMCQF
| — | LOCK|SlN< | $13B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|<&Y<Nx | LOCK|f!qnC | $13B | |||
| Encompass Health Corp
EHC
| — | LOCK|MW?d | $11B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|$klp$^ | LOCK|><r#! | $9B | |||
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|<>% | LOCK|>vB | $12,220 |
United States